Skip to content

ALLO - Allogene Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Allogene Therapeutics Inc

ALLO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ALLOAllogene Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $4.46
52-wk low: $1.04
Prev close: $3.10
Mkt cap: $770.4M
Beta: 0.47
P/S: 166.0x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$212.4M

PR
PRIMECAP
Q2 2026 13F
$27.3M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 18.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $770M

Valuation

P/S166.04
P/B1.61

Quality

Operating margin-1011.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ALLO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $770.45M
Beta: 0.47

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.6x

Profit margin

+0.0%

Op margin

-1011.0%

ROE

-42.4%

$21.0M

position

TS

Two Sigma

Q2 2026 13F

$16.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ALLO

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.13+18.8%

-$0.16 expected

Next report

What the street expects next

EPS expected

-$0.14

-$0.18 to -$0.09

Revenue expected

$0.00

9 analysts

Last 30 days

2up0down

Analysts raising estimates

-42.4%

ROA-22.1%

Growth

Beta0.47